KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Retained Earnings (2016 - 2025)

Neogenomics' Retained Earnings history spans 16 years, with the latest figure at -$433.8 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 33.16% year-over-year to -$433.8 million; the TTM value through Dec 2025 reached -$433.8 million, down 33.16%, while the annual FY2025 figure was -$433.8 million, 33.16% down from the prior year.
  • Retained Earnings reached -$433.8 million in Q4 2025 per NEO's latest filing, down from -$423.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $26.9 million in Q3 2021 to a low of -$433.8 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$131.9 million, with a median of -$57.2 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: surged 219.11% in 2021, then plummeted 29794.29% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$14.8 million in 2021, then soared by 73.72% to -$3.9 million in 2022, then surged by 57.07% to -$1.7 million in 2023, then plummeted by 19361.23% to -$325.8 million in 2024, then crashed by 33.16% to -$433.8 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Retained Earnings are -$433.8 million (Q4 2025), -$423.9 million (Q3 2025), and $29000.0 (Q2 2025).